AGA Perspectives August/September 2011
 |
Examining The Use of PPIsAre PPIs prescribed indiscriminately or is their broad use justified? Widespread use of PPIs: are these agents safe for long-term use? What are the real risks, and how can we minimize possible downsides of PPI use? Long-Term PPI Therapy Risks: “Keep Calm and Carry On” Is It Time to Dismiss the PPI Safety Concerns? |
Also in this issue…
Pregnancy and IBD: How to Best Communicate Risks and Benefits to Patients and the Obstetrician
Uma Mahadevan, MD
Increasing CRC Screening in Minorities and Disadvantaged Populations: Our Success Story
Steven H. Itzkowitz, MD, AGAF, FACP, FACG, and Lina Jandorf
Staging Liver Fibrosis: Liver Biopsy, Imaging and Biomarkers
Nezam H. Afdhal, MD
ACOs — How Will They Affect Patient Care?
John I. Allen, MD, MBA, AGAF; Joel V. Brill, MD, AGAF; Lawrence S. Kim, MD, AGAF;and Lawrence R. Kosinski, MD, MBA, AGAF
Transplant Hepatology: Three or Four Years of Training?
Deborah D. Proctor, MD, AGAF
Volunteering After the Earthquake in Haiti
Kenneth B. Klein, MD
Integrating Registries Into Practice Improves Quality, Enhances Business
John I. Allen, MD, MBA, AGAF
Talented and Diverse Leaders Working for You
Download the full issue as a PDF.
0 out of 0 users found this page helpful.
Was this page helpful?
Only current members of the American Gastroenterological Association may post comments to this page.
Login To Comment
